STSA Latest Press Releases, Satsuma Pharmaceuticals, Inc. Corporate News

Releases

1.100

0.00%

0.000

All
Financials
Insiders

8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
May 18,2023 16:30
10-Q | Satsuma Pharmaceuticals, Inc.(0001692830)
May 11,2023 16:08
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
May 03,2023 16:12
SC 13D/A | Satsuma Pharmaceuticals, Inc.(0001692830)
May 02,2023 17:27
10-K/A | Satsuma Pharmaceuticals, Inc.(0001692830)
Apr 28,2023 16:13
SC 13D/A | Satsuma Pharmaceuticals, Inc.(0001692830)
Apr 18,2023 16:31
SC 13D/A | Satsuma Pharmaceuticals, Inc. (0001692830)
Apr 17,2023 16:09
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Apr 17,2023 07:00
10-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Mar 28,2023 16:55
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Mar 28,2023 16:54
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Feb 16,2023 16:04
SC 13G/A | Satsuma Pharmaceuticals, Inc.(0001692830)
Feb 14,2023 13:45
SC 13G/A | Satsuma Pharmaceuticals, Inc.(0001692830)
Feb 10,2023 16:20
SC 13G/A | Satsuma Pharmaceuticals, Inc.(0001692830)
Feb 08,2023 16:57
SC 13D/A | Satsuma Pharmaceuticals, Inc.(0001692830)
Jan 27,2023 16:58
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Dec 20,2022 16:22
4/A | Satsuma Pharmaceuticals, Inc.(0001692830)
Dec 09,2022 16:12
UPLOAD | Satsuma Pharmaceuticals, Inc.(0001692830)
Dec 07,2022 07:55
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 30,2022 16:02
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 23,2022 09:39
SC 13G | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 16,2022 16:47
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 16,2022 16:39
SC 13G/A | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 16,2022 16:14
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 16,2022 16:14
3 | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 16,2022 16:00
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 14,2022 16:16
EFFECT | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 08,2022 06:35
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 03,2022 16:55
424B5 | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 03,2022 16:54
10-Q | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 03,2022 16:32
CORRESP | Satsuma Pharmaceuticals, Inc. (0001692830)
Nov 03,2022 16:10
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Nov 03,2022 16:06
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Oct 28,2022 16:04
S-3 | Satsuma Pharmaceuticals, Inc.(0001692830)
Oct 28,2022 06:12
8-K | Satsuma Pharmaceuticals, Inc. (0001692830)
Sep 20,2022 17:03
10-Q | Satsuma Pharmaceuticals, Inc.(0001692830)
Aug 09,2022 16:30
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Aug 09,2022 16:20
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 17:47
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 17:47
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 17:47
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 17:47
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 17:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 17:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 17:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 17:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 17:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 17:38
4 | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 17:38
8-K | Satsuma Pharmaceuticals, Inc.(0001692830)
Jun 07,2022 06:40
10-Q | Satsuma Pharmaceuticals, Inc. (0001692830)
May 10,2022 16:19

Webull provides the latest Satsuma Pharmaceuticals, Inc. (STSA) stock and general news. This information may help you make smarter investment decisions.

About STSA

Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a therapeutic product for the acute treatment of migraine. The Company's product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate (DHE), which is designed to self-administered with a pre-filled, single-use, nasal delivery device. STS101 also incorporates an improved 2nd-generation nasal delivery device. STS101 is specifically designed to deliver the clinical advantages of DHE while overcoming its shortcomings.